First human test of new drug begins
NCT ID NCT07295717
Summary
This is the first study in humans for the investigational drug ALN-4285. It aims to test the safety and how the body processes a single injection of the drug in 76 healthy adult volunteers. The study will start with low doses and gradually increase them to find a safe range for future research.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Trial Site
RECRUITINGLondon, NW10 7EW, United Kingdom
Conditions
Explore the condition pages connected to this study.